- 专利标题： MORPHINAN DERIVATIVES FOR THE TREATMENT OF OPIOID DELTA RECEPTOR AGONIST-RELATED DISEASES
-
申请号： EP24165019.1申请日： 2017-09-15
-
公开(公告)号： EP4414037A3公开(公告)日： 2024-08-21
- 发明人: NAGASE, Hiroshi , FUJII, Hideaki , SAITOH, Akiyoshi , NAKATA, Eriko , HIROSE, Masaaki , OOI, Isao , HAYASHIDA, Kohei
- 申请人： Nippon Chemiphar Co., Ltd.
- 申请人地址： JP Tokyo 101-0032 2-2-3, Iwamoto-cho, Chiyoda-ku
- 专利权人： Nippon Chemiphar Co., Ltd.
- 当前专利权人： Nippon Chemiphar Co., Ltd.
- 当前专利权人地址： JP Tokyo 101-0032 2-2-3, Iwamoto-cho, Chiyoda-ku
- 代理机构： Godemeyer Blum Lenze Patentanwälte Partnerschaft mbB - werkpatent
- 优先权： JP 16203925 2016.09.16
- 分案原申请号： 17851013.7 2017.09.15
- 主分类号： A61K31/485
- IPC分类号： A61K31/485 ; A61K31/439 ; A61K31/444 ; A61K31/4709 ; A61K31/497 ; A61K31/501 ; A61K31/506 ; A61P21/00 ; A61P25/04 ; A61P25/06 ; A61P25/22 ; A61P25/24 ; A61P43/00
摘要：
The present invention relates to a pharmaceutical composition comprising a morphinan derivative that exhibits an opioid δ receptor agonist activity. By administering the pharmaceutical composition provided by the present invention, opioid δ receptor-related diseases (for example, a depression as a symptom associated with Alzheimer's disease) can be treated or prevented.
公开/授权文献
信息查询
IPC分类:
